Skip to main content

Antiproteases: Effective Treatment with Gabexate Mesilate

  • Chapter
Acute Pancreatitis
  • 138 Accesses

Abstract

Since the introduction of Chiari’s concept of “tryptic autodigestion” of the pancreatic gland in 1869 [7], several pancreatic enzymes have been implicated as triggers of acute pancreatitis. However, the initiating factor(s) has still not been clarified. Many of the pancreatic enzymes have been suggested. Activated proteases, such as trypsin [5, 10] and elastase [33, 36], have been found in complex with protease inhibitors in both blood and peritoneal fluid [24, 25]. The probable role of granulocyte proteases has also been emphasized [6, 20]. All these findings indicate liberation of active proteases during the disease. In addition, some studies have shown activation of the different cascade systems of the body, such as the complement, kinin, coagulation and fibrinolytic systems. A similar activation has also been shown in other conditions in which active proteases are set free, for example, sepsis [26, 31], abscesses [17], burns [17] and multiple trauma [17, 19]. The clinical importance of these biochemical events and of their interrelation is, as yet, not fully understood.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Balldin G (1980) On protease-antiprotease imbalance with special reference to the protective role of protease inhibitors in acute pancreatitis. Thesis, Malmö

    Google Scholar 

  2. Balldin G, Eddeland A, Ohlsson K (1981) Studies on the role of the plasma protease inhibitors on C3-activation in vitro and in acute pancreatitis. Scand J Gastroenterol 16:603–609

    Article  PubMed  CAS  Google Scholar 

  3. Balldin G, Ohlsson K (1979) Demonstration of pancreatic protease-antiprotease complexes in the peritoneal fluid of patients with acute pancreatitis. Surgery 85:451–456

    PubMed  CAS  Google Scholar 

  4. Barrett AJ, Starkey PM (1973) The interaction of alpha-2-macroglobulin with proteinases. Biochem J 133:709–724

    PubMed  CAS  Google Scholar 

  5. Borgström A, Ohlsson K (1978) Immunoreactive trypsin in serum and peritoneal fluid in acute pancreatitis. Hoppe Seylers Z Physiol Chem 359:677 — 681

    PubMed  Google Scholar 

  6. Brower MS, Harpel PC (1982) Proteolytic cleavage and inactivation of alpha-2-plasmin inhibitor and Cl-inactivator by human polymorphonuclear leucocyte elastase. J Biol Chem 257:9849–9854

    PubMed  CAS  Google Scholar 

  7. Chiari H (1896) Über die Selbstverdauung des menschlichen Pankreas. Z Heilkd 17:69–96

    Google Scholar 

  8. Creutzfeldt W, Schmidt H (1970) Aetiology and pathogenesis of pancreatitis (current concepts). Scand J Gastroenterol [Suppl] 6:47 — 62

    CAS  Google Scholar 

  9. Dürr HK (1979) Acute pancreatitis. In: Howat HT, Sarles H (eds) The exocrine pancreas. Saunders, London

    Google Scholar 

  10. Elias E, Redshaw M, Wood T (1977) The diagnostic importance of changes in circulating concentrations of immunoreactive trypsin. Lancet 2:66–68

    Article  PubMed  CAS  Google Scholar 

  11. Freise J (1983) Inhibition of phospholipase A2 by gabexate mesilate, camostate and aprotinine. Enzyme 30:209

    PubMed  CAS  Google Scholar 

  12. Freise J, Melzer P, Schmidt FW, Horbach L (1986) Gabexat Mesilat in der Behandlung der akuten Pankreatitis. Ergebnisse der Hannoverschen multizentrischen Doppelblindstudie mit 50 Patienten. Z Gastroenterol 24:200–211

    PubMed  CAS  Google Scholar 

  13. Freise J, Schmidt FW (1984) Gabexat Mesilat (FOY) in der Behandlung der akuten Pankreatitis. Z Gastroenterol 22:531 (Abstract)

    Google Scholar 

  14. Fritz H, Krück J (1979) Immunofluorescence studies indicate that the basic trypsin-kal-likrein-inhibitor of bovine organs (Trasylol) originates from mast cells. Hoppe Seylers Z Physiol Chem 360:437–444

    Article  PubMed  CAS  Google Scholar 

  15. Fritz H, Oppitz KH, Meckl D, Kemkes B, Haendle H, Schult H, Werle E (1969) Verteilung und Ausscheidung von natürlich vorkommenden und chemisch modifizierten Proteaseinhibitoren nach intravenöser Injektion bei Ratte, Hund (und Mensch). Hoppe Seylers Z Physiol Chem 350:1541–1550

    Article  PubMed  CAS  Google Scholar 

  16. Geokas MC, Largman C, Durie PR, Brodrick JW, Ray SB, O’Rourke M, Vollmer J (1981) Immunoreactive forms of cationic trypsin in plasma and ascites fluid of dogs in experimental pancreatitis. Am J Pathol 105:31–39

    PubMed  CAS  Google Scholar 

  17. Heideman M, Saravis C, Clowes GHA (1982) Effect of nonviable tissue and abscesses on complement depletion and the development of bacteremia. J Trauma 22:527–532

    Article  PubMed  CAS  Google Scholar 

  18. Kazal LA, Spicer DS, Brahinsky RA (1948) Isolation of a crystalline trypsin inhibitor. J Am Chem Soc 70:3034–3040

    Article  PubMed  CAS  Google Scholar 

  19. Kierulf P, Aasen AO, Aune S, Godai MC, Ruud TE, Vaage J (1982) Chromogenic peptide substrate assays in patients with multiple trauma. Acta Chir Scand [Suppl] 509:69–72

    CAS  Google Scholar 

  20. Klingemann HG, Egbring R, Holst F, Gramse M, Havemann K (1981) Digestion of alpha-2-plasmin inhibitor by neutral proteases from human leucocytes. Thromb Res 24:479–483

    Article  PubMed  CAS  Google Scholar 

  21. Kraut H, Frey EK, Werle E (1930) Über die Inaktivierung des Kallikreins. Hoppe Seylers Z Physiol Chem 192:1–21

    Article  CAS  Google Scholar 

  22. Kunitz M, Northrop JH (1936) Isolation from beef pancreas of crystalline trypsinogen, trypsin, a trypsin inhibitor, and an inhibitor-trypsin compound. J Gen Physiol 19:991–1007

    Article  PubMed  CAS  Google Scholar 

  23. Lake-Bakaar G, McKavanagh S, Gatus B, Summerfleld JA (1980) The relative values of serum immuno-reactive trypsin concentration and total amylase activity in the diagnosis of mumps, chronic renal failure, and pancreatic disease. Scand J Gastroenterol 15:97–101

    Article  PubMed  CAS  Google Scholar 

  24. Lasson A, Ohlsson K (1984) Protease inhibitors in acute human pancreatitis. Correlation between biochemical changes and clinical course. Scand J Gastroenterol 19:779–786

    PubMed  CAS  Google Scholar 

  25. Lasson A, Ohlsson K (1984) Acute pancreatitis. The correlation between clinical course, protease inhibitors, and complement and kinin activation. Scand J Gastroenterol 19:707–710

    PubMed  CAS  Google Scholar 

  26. McConn R, Wasserman F, Haberland G (1982) The role of chemical mediators in the pathophysiology of acute illness and injury. Raven, New York

    Google Scholar 

  27. McMahon MJ, Bowen M, Mayer AD, Cooper EH (1984) Relation of alpha-2-macro-globulin and other antiproteases to the clinical features of acute pancreatitis. Am J Surg 147:164–170

    Article  PubMed  CAS  Google Scholar 

  28. Nevalainen TJ (1980) The role of phospholipase A in acute pancreatitis. Scand J Gastroenterol 15:641–650

    Article  PubMed  CAS  Google Scholar 

  29. O’Connor CM, O’Donnell MD, McGeeney KF (1981) Problems associated with the radioimmunoassay of serum trypsin. Clin Chim Acta 114:29–35

    Article  PubMed  Google Scholar 

  30. Opie EL (1901) The etiology of acute hemorrhagic pancreatitis. Bull Johns Hopk Hosp 12:182–188

    Google Scholar 

  31. Smith-Erichsen N, Aasen AO, Amundsen E (1982) Treatment of sepsis in the surgical patient evaluated by means of chromogenic peptide substrate assays. Acta Chir Scand [Suppl] 509:33–38

    CAS  Google Scholar 

  32. Tanaka N, Tsuchiya R, Ishii K (1979) Comparative clinical study of FOY and Trasylol in acute pancreatitis. In: Fuji S, Meriva H, Suzuki T (eds) Kinins II: systemic proteases and cellular function. Plenum, New York

    Google Scholar 

  33. Toki N, Takasugi S, Sumi H (1982) Isolation and characterization of a pancreatic elastase from plasma of patients with acute pancreatitis. Clin Sei 62:321–328

    PubMed  CAS  Google Scholar 

  34. Vincent JP, Lazdunski M (1976) Pre-existence of the active site in zymogens, the interaction of trypsinogen with the basic pancreatic trypsin inhibitor (Kunitz). FEBS Lett 63:240–244

    Article  PubMed  CAS  Google Scholar 

  35. Vogel R, Trautschold I, Werle E (1966) Natural protease inhibitors — biochemistry and clinical aspects. Thieme, Stuttgart

    Google Scholar 

  36. Wellborn JC, Alston JD, Cannon DJ, Read RC (1983) Serum proteolytic and antiproteolytic activity in acute pancreatitis. Am J Surg 146:834–837

    Article  PubMed  CAS  Google Scholar 

  37. Wendt P, Fritsch A, Schulz F, Wunderlich G, Blümel G (1984) Proteinases and inhibitors in plasma and peritoneal exudate in acute pancreatitis. Hepatogastroenterology 31:277–281

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Singer, M.V., Goebell, H. (1987). Antiproteases: Effective Treatment with Gabexate Mesilate. In: Beger, H.G., Büchler, M. (eds) Acute Pancreatitis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83027-3_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83027-3_37

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-83029-7

  • Online ISBN: 978-3-642-83027-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics